NEW YORK, Feb. 21, 2014 (GLOBE NEWSWIRE) -- Levi & Korsinsky notifies investors of LCA-Vision Inc. ("LCA" or "the Company") (Nasdaq:LCAV) of claims of breaches of fiduciary duty and other violations of state law against the board of directors of the Company in connection with the sale of the Company to PhotoMedex, Inc. (Nasdaq:PHMD). A complaint was filed in Delaware state court.
Click here to learn more: http://zlk.9nl.com/lca-vision-lcav, or call: 877-363-5972. There is no cost or obligation to you.
Under the terms of the transaction, LCA shareholders will receive $5.37 for each share of LCA common stock they own. The transaction has a total approximate value of $106.4 million. The claims concern whether the LCA Board breached their fiduciary duties to stockholders by failing to adequately shop the Company before agreeing to enter into this transaction, and whether PhotoMedex, Inc. is underpaying for LCA shares. In particular, at least one analyst set a price target for LCA stock at $8.00 per share.
If you own LCA-Vision common stock and wish to obtain additional information, please contact Joseph E. Levi, Esq. either via email at jlevi@zlk.com or by telephone at (212) 363-7500, toll-free: (877) 363-5972, or visit http://zlk.9nl.com/lca-vision-lcav.
Levi & Korsinsky is a national firm with offices in New York, New Jersey, Connecticut and Washington D.C. The firm's 26 attorneys have extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities and shareholder lawsuits. For more information, please feel free to contact any of the attorneys listed below. Attorney advertising. Prior results do not guarantee similar outcomes.